Results 191 to 200 of about 31,538 (351)

Water Soluble Bone Hemostatic Agent, Was It Effective In Reducing Post-Sternotomy Wound Infection?

openalex   +1 more source

Menstrual suppression to decrease intrauterine device expulsion in adolescents with inherited bleeding disorders

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 421-423, April 2025.
Peter H. Cygan, Kelly M. Kons, Megan H. Fiorillo, Tonya S. Wright   +3 more
wiley   +1 more source

Association Between Postoperative NSAID Use and Bleeding Following Transoral Robotic Surgery

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To evaluate the safety and outcomes of NSAID use following transoral robotic surgery (TORS). Study Design Retrospective cohort study using propensity score matching. Setting Multi‐institutional database (TriNetX). Methods Patients undergoing TORS were identified using ICD‐10 codes.
Brayden Seliger, Jacob Beiriger, Milana Berry, Nilam Patel, Richard B. Cannon, Marcus M. Monroe, Hilary C. McCrary   +6 more
wiley   +1 more source

Concerns with intramyometrial vasopressin as a hemostatic agent

Bali Journal of Anesthesiology, 2021
Rejitha Chandrasekharan, Iti Shree
doaj   +1 more source

A novel polysaccharide hemostatic agent in prevention of post-procedural bleeding following large colonic polyp resection. [PDF]

Endosc Int Open
Auriemma F, Franchellucci G, Andrisani G, Di Matteo F, De Luca L, De Deo D, Calabrese F, Fiacca M, Minnini F, Paduano D, Gentile C, Petrillo P, Ramai D, Facciorusso A, Repici A, Mangiavillano B.   +15 more
europepmc   +1 more source

Evaluation of the effects of three natural products and a hemostatic agent on wound healing: an experimental study. [PDF]

Turk J Med Sci, 2023
Yılmaz AÇ, Aygın D.
europepmc   +1 more source

A novel technique: hemostatic agents for port-site closure post robotic-assisted urological surgeries. a pilot study [PDF]

, 2020
Abdulrahman M. Alsuwailim
openalex   +1 more source

Hemophilia A: An Ideal Disease for Prenatal Therapy

Prenatal Diagnosis, EarlyView.
ABSTRACT Hemophilia A (HA) is the most common inherited coagulation defect. Current state‐of‐the‐art treatment consists of frequent administration of prophylactic infusions of coagulation factor VIII (FVIII) protein or bispecific antibodies that replace the cofactor function of FVIIIa to maintain hemostasis. However, these treatments are far from ideal,
Christopher D. Porada, Anthony Atala, Graça Almeida‐Porada   +2 more
wiley   +1 more source

Efficacy and safety of a novel absorbable bone wax as a hemostatic agent for periacetabular osteotomy: a prospective, randomized controlled trial. [PDF]

BMC Musculoskelet Disord
Wu J, Peng J, Xiao F, Zheng X, Zhu H, Liu C, Han X, Chen X.   +7 more
europepmc   +1 more source

Is L-PRF an effective hemostatic agent in single tooth extractions? A cohort study on VKA and DOAC patients. [PDF]

Clin Oral Investig, 2023
Berton F, Costantinides F, Stacchi C, Corradini A, Di Lenarda A, Di Lenarda R.   +5 more
europepmc   +1 more source